PLASREVO · Evolution of plasmid-mediated resistance in Pseudomonas aeruginosa
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2012-10-01 → 2014-09-30
- Финансиране от ЕС
- 200 372 €
- Участници
- 1
- Схема
- MC-IEF
Линиите свързват координатора с партньорите.
Накратко на български
Плазмидите при бактерията Pseudomonas aeruginosa се изследват, за да се разбере как взаимодействието между тях помага за тяхното оцеляване. Това обяснява защо бактериите често запазват устойчивостта си към антибиотици, дори когато лекарствата вече не се използват.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Evolution of plasmid-mediated resistance in Pseudomonas aeruginosa
Overview of the results Introduction Plasmids play a key role in bacterial evolution by allowing bacteria to adapt to novel environmental pressures; for example, the rapid evolution of antibiotic resistance in many pathogenic bacteria has been driven by plasmids. However, it remains challenging to understand how plasmids can persist in bacterial populations over the long term, and this has been termed the “plasmid paradox” [1]. This paradox arises because positive selection for plasmid-encoded traits is likely to be transient, but plasmids impose a fitness burden on their hosts, and can be lost at cell division. Classical models predict that horizontal gene transfer is required to maintain plasmids [2,3], but recent analyses of bacterial genomes have shown that almost half of plasmids are non-transmissible [4]. First year [5] In our first year, we use a combination of experimental and bioinformatic methods to study how epistatic interactions between plasmids contribute to plasmid persistence. First, we demonstrate that positive epistasis between co-infecting plasmids in Pseudomonas aeruginosa minimizes the cost associated with plasmid carriage and increases plasmid stability at a population level using experimental evolution. Second, we demonstrate that the patterns of distribution of plasmids across all sequenced bacterial genomes are consistent with the hypothesis that positive epistasis maintains plasmids in environmental and clinical populations. We anticipate that this study will be of broad interest to researchers who are interested in microbial evolutionary biology and plasmid biology because it provides a novel, and potentially very general, solution to the plasmid paradox and it helps to explain why antibiotic resistance is rarely lost after antibiotic use is discontinued in pathogen populations [6]. Second year [7] How can we explain the maintenance of non-transmissible plasmids? In this work, we address this question using a combination of experimental evolution, mathematical modelling and whole genome sequencing. We show that a costly and highly unstable plasmid, pNUK73, can be rapidly stabilized in populations of the pathogenic bacterium P. aeruginosa by a combination of compensatory adaptation and positive selection. Compensatory adaptation by P. aeruginosa recovers the cost associated with plasmid carriage, but compensation alone is not sufficient to maintain the plasmid as a result of segregational loss of plasmids. Positive selection mediated by exposure to antibiotics is necessary to increase plasmid frequency and offset the effects of segregational loss. Crucially, we find that feedback occurs between these processes. Positive selection increases the efficacy of selection for compensatory adaptation by increasing the population size of plasmid-bearing lineages. Compensatory adaptation, in turn, increases the effect of positive selection on plasmid stability by slowing the rate at which the plasmid is lost between episodes of positive selection. Therefore, we argue that it is the interaction between compensatory adaptation and positive selection that helps to stabilize non-conjugative plasmids in bacterial populations. Conclusions and the socio-economic impacts of the project Antibiotic resistance is currently one of the major threats to human health in developed countries [8,9] and plasmids play a major role in the spread of antibiotic resistance determinants among bacterial pathogens. The results obtained in this project help to understand the ecological and evolutionary bases of the maintenance of plasmid-mediated antibiotic resistance in bacterial populations, which is essential to develop new strategies to combat this threat. 1. Harrison E, Brockhurst MA (2012) Plasmid-mediated horizontal gene transfer is a coevolutionary process. Trends Microbiol 20: 262-267. 2. Stewart FM, Levin BR (1977) The Population Biology of Bacterial Plasmids: A PRIORI Conditions for the Existence of Conjugationally Transmitted Factors. Genetics 87: 209-228. 3. Bergstrom CT, Lipsitch M, Levin BR (2000) Natural selection, infectious transfer and the existence conditions for bacterial plasmids. Genetics 155: 1505-1519. 4. Smillie C, Garcillán-Barcia MP, Francia MV, Rocha EP, de la Cruz F (2010) Mobility of plasmids. Microbiol Mol Biol Rev 74: 434-452. 5. San Millan A, Heilbron K, MacLean RC (2014) Positive epistasis between co-infecting plasmids promotes plasmid survival in bacterial populations. ISME J 8: 601-612. 6. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271. 7. San Millan A, Peña-Miller R, Toll-Riera M, Halbert ZV, McLean AR, et al. (2014) Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nature Communications. 8. eCDC (2013) European Center for Disease Prevention and Control. Annual Epidemiological Report 2012. http://www.ecdc.europa.eu/en/publications/surveillance_reports/Pages/index.aspx. 9. CDC (2013) Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. http://www.cdc.gov/drugresistance/threat-report-2013 Alvaro San Millan DVM PhD Marie Curie Research Fellow Department of Zoology University of Oxford South Parks Road Oxford OX1 3PS http://www.zoo.ox.ac.uk/people/view/sanmillan_a.htm
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Antimicrobial resistance in bacteria is currently one of the most concerning threats for public health. Up to 400,000 patients suffer from infections resistant to multiple antibiotics in Europe annually, giving rise to more than 18,000 deaths every year. Hence, a better control of the rise and spread of antimicrobial resistance in pathogenic bacteria is crucial to improve the health of European citizens. Bacteria acquire resistance to antibiotics through two principal routes, (i) chromosomal mutations and (ii) plasmid acquisition. Plasmids are extrachromosomal DNA elements responsible for the spread of antimicrobial resistance determinants among bacteria, as they can disseminate by horizontal gene transfer (conjugation and/or transformation).Previous works have shown that aspects as the mechanistic basis of drug resistance and the antibiotic treatment regimes are crucial for understanding the evolution of population genetics of chromosomal-mediated resistance. Here, we would like to determine the key population genetic parameters that influence the rising and the spread of plasmid-mediated resistance. Specifically, we will determine for both (a) plasmid and (b) chromosomal-mediated resistance:(i)The rate of acquisition of resistance.(ii)The fitness costs and benefits of resistance.(iii)The potential for compensatory adaptation to ameliorate the cost of resistance.We will quantify these parameters using in vivo and in vitro experimental evolution experiments with the pathogenic bacterium Pseudomonas aeruginosa.This work will help us to understand and prevent the concerning phenomenon of antimicrobial resistance spread among pathogenic bacteria, and will provide information of biological and clinical relevance to make predictions about how innovative therapeutic approaches could impact plasmid-mediated resistance dynamics.""
Оригинален текст от CORDIS (на английски).
Участници
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
